BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,186,885 | -17.2% | 31,449 | 0.0% | 0.01% | -20.0% |
| Q2 2023 | $1,432,816 | -40.5% | 31,449 | -51.2% | 0.01% | -41.2% |
| Q1 2023 | $2,407,953 | -38.4% | 64,500 | -15.9% | 0.02% | -34.6% |
| Q4 2022 | $3,909,522 | -15.1% | 76,706 | -10.3% | 0.03% | -18.8% |
| Q3 2022 | $4,607,000 | +64.7% | 85,534 | +96.4% | 0.03% | +39.1% |
| Q2 2022 | $2,797,000 | -17.9% | 43,545 | -0.9% | 0.02% | 0.0% |
| Q1 2022 | $3,406,000 | -10.3% | 43,925 | -0.7% | 0.02% | -4.2% |
| Q4 2021 | $3,798,000 | -3.4% | 44,245 | -9.5% | 0.02% | -11.1% |
| Q3 2021 | $3,933,000 | -5.5% | 48,902 | -5.4% | 0.03% | -3.6% |
| Q2 2021 | $4,162,000 | -55.5% | 51,699 | -57.4% | 0.03% | -64.1% |
| Q1 2021 | $9,353,000 | -3.9% | 121,346 | 0.0% | 0.08% | +1.3% |
| Q4 2020 | $9,737,000 | +144.3% | 121,346 | +144.9% | 0.08% | +108.1% |
| Q3 2020 | $3,985,000 | -9.8% | 49,559 | -3.4% | 0.04% | -21.3% |
| Q2 2020 | $4,418,000 | -8.6% | 51,314 | -13.2% | 0.05% | -13.0% |
| Q1 2020 | $4,835,000 | -2.2% | 59,147 | +0.0% | 0.05% | +1.9% |
| Q4 2019 | $4,945,000 | -2.3% | 59,138 | +2.2% | 0.05% | -20.9% |
| Q3 2019 | $5,063,000 | -34.0% | 57,887 | -21.8% | 0.07% | -30.2% |
| Q2 2019 | $7,674,000 | +93.0% | 74,046 | +51.4% | 0.10% | +88.2% |
| Q1 2019 | $3,976,000 | +23.5% | 48,892 | -0.0% | 0.05% | +4.1% |
| Q4 2018 | $3,219,000 | +11.6% | 48,913 | +30.8% | 0.05% | +28.9% |
| Q3 2018 | $2,884,000 | +2.4% | 37,406 | -1.9% | 0.04% | -15.6% |
| Q2 2018 | $2,817,000 | +7.4% | 38,148 | -5.4% | 0.04% | 0.0% |
| Q1 2018 | $2,622,000 | -26.8% | 40,319 | -27.2% | 0.04% | -27.4% |
| Q4 2017 | $3,582,000 | -20.8% | 55,419 | -23.1% | 0.06% | -21.5% |
| Q3 2017 | $4,521,000 | +10.6% | 72,054 | +6.7% | 0.08% | +2.6% |
| Q2 2017 | $4,087,000 | +61.0% | 67,509 | +37.9% | 0.08% | +57.1% |
| Q1 2017 | $2,539,000 | +40.8% | 48,963 | +20.4% | 0.05% | +19.5% |
| Q4 2016 | $1,803,000 | -1.6% | 40,673 | +5.7% | 0.04% | -6.8% |
| Q3 2016 | $1,832,000 | +20.8% | 38,484 | +14.8% | 0.04% | +12.8% |
| Q2 2016 | $1,516,000 | +25.5% | 33,524 | +13.4% | 0.04% | +30.0% |
| Q1 2016 | $1,208,000 | +74.6% | 29,558 | +40.4% | 0.03% | +76.5% |
| Q3 2015 | $692,000 | -91.1% | 21,056 | -80.9% | 0.02% | -89.5% |
| Q2 2015 | $7,782,000 | +138.7% | 110,148 | +131.5% | 0.16% | +145.5% |
| Q1 2015 | $3,260,000 | -15.7% | 47,583 | -9.9% | 0.07% | -18.5% |
| Q4 2014 | $3,868,000 | – | 52,783 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |